Literature DB >> 12651204

Outcome analysis of 189 consecutive cancer patients referred to the intensive care unit as emergencies during a 2-year period.

G Maschmeyer1, F-L Bertschat, K T Moesta, E Häusler, T K Held, M Nolte, K-J Osterziel, V Papstein, M Peters, G Reich, M Schmutzler, O Sezer, M Stula, H Wauer, T Wörtz, M Wischnewsky, P Hohenberger.   

Abstract

The referral of critically ill cancer patients to an intensive care unit (ICU) is a matter of controversial debate. This study was conducted by an interdisciplinary clinical group to evaluate the outcome of ICU treatment in cancer patients according to their characteristics at the time of referral. A retrospective analysis was used to identify relevant subgroups among 189 consecutive cancer patients referred as emergencies to one of four ICUs during a 2-year period. Reasons for ICU referral were pneumonia (29.6%), sepsis (27.0%), fungal infection (11.1%), another infection (9.5%), gastrointestinal emergency (16.9%), treatment-related organ toxicity (6.9%), or other, non-infectious complications (43.9%). Vasopressor support was required in 50.3%, mechanical ventilation in 49.7%, and haemodialysis/-filtration in 26.5% of the patients. Overall, 41.3% died during ICU treatment, 12.2% died after transfer from ICU to a non-ICU ward, and 35.4% were discharged alive. Sepsis, mechanical ventilation, vasopressor support, renal replacement therapy and neutropenia were independent risk factors for fatal outcome, but no single risk factor unequivocally predicted death. All patients with fungal infection who required vasopressor support and either had sepsis (n=13) or needed mechanical ventilation (n=14) died during ICU treatment, while all non-septic patients. who did not require mechanical ventilation, were younger than 74 years of age and had a non-infectious underlying complication (n=29), survived. This analysis may help to early identify relevant subgroups of cancer patients with different prognoses under ICU treatment. A prospective study to confirm the predictive usefulness of this approach is needed. Cancer patients should not be excluded from referral to the intensive care unit in an emergency solely due to their underlying malignant disease or a single unfavourable prognostic factor.

Entities:  

Mesh:

Year:  2003        PMID: 12651204     DOI: 10.1016/s0959-8049(03)00004-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  15 in total

1.  Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic cancer patients.

Authors:  Georg Maschmeyer
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

2.  Intensive care unit mortality in solid tumor patients: is this predictable and preventable?

Authors:  Antonio M Esquinas; Egbert Pravinkumar
Journal:  Support Care Cancer       Date:  2013-09-27       Impact factor: 3.603

3.  [Mortality of hematology-oncology patients with neutropenia in intensivecare].

Authors:  I Suárez; B Böll; A Shimabukuro-Vornhagen; G Michels; M von Bergwelt-Baildon; M Kochanek
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-05-21       Impact factor: 0.840

4.  Has survival increased in cancer patients admitted to the ICU? No.

Authors:  Frédéric Pène; Jorge I F Salluh; Thomas Staudinger
Journal:  Intensive Care Med       Date:  2014-08-27       Impact factor: 17.440

5.  Characteristics and outcomes of patients with hematologic malignancies receiving chemotherapy in the intensive care unit.

Authors:  Stephen M Pastores; Debra A Goldman; David J Shaz; Natalie Kostelecky; Ryan J Daley; Tim J Peterson; Kay See Tan; Neil A Halpern
Journal:  Cancer       Date:  2018-05-04       Impact factor: 6.860

6.  Outcome and predictors of mortality in patients requiring invasive mechanical ventilation due to acute respiratory failure while undergoing ambulatory chemotherapy for solid cancers.

Authors:  So Young Park; So Yeon Lim; Sang-Won Um; Won-Jung Koh; Man Pyo Chung; Hojoong Kim; O Jung Kwon; Hye Kyeong Park; Seok Jin Kim; Young Hyuck Im; Myung-Ju Ahn; Gee Young Suh
Journal:  Support Care Cancer       Date:  2013-01-12       Impact factor: 3.603

7.  Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit: a single-center experience.

Authors:  Christelle Ferrà; Pilar Marcos; Maite Misis; Mireia Morgades; María-Luisa Bordejé; Albert Oriol; Natalia Lloveras; Juan-Manuel Sancho; Blanca Xicoy; Montserrat Batlle; Jordi Klamburg; Evarist Feliu; Josep-Maria Ribera
Journal:  Int J Hematol       Date:  2007-04       Impact factor: 2.490

8.  Intensive care admission of cancer patients: a comparative analysis.

Authors:  Monique M E M Bos; Ilona W M Verburg; Ineke Dumaij; Jacqueline Stouthard; Johannes W R Nortier; Dick Richel; Eric P A van der Zwan; Nicolette F de Keizer; Evert de Jonge
Journal:  Cancer Med       Date:  2015-04-18       Impact factor: 4.452

9.  Characteristics and outcomes of cancer patients in European ICUs.

Authors:  Fabio Silvio Taccone; Antonio A Artigas; Charles L Sprung; Rui Moreno; Yasser Sakr; Jean-Louis Vincent
Journal:  Crit Care       Date:  2009-02-06       Impact factor: 9.097

10.  Performance of six severity-of-illness scores in cancer patients requiring admission to the intensive care unit: a prospective observational study.

Authors:  Márcio Soares; Flávia Fontes; Joana Dantas; Daniela Gadelha; Paloma Cariello; Flávia Nardes; César Amorim; Luisa Toscano; José R Rocco
Journal:  Crit Care       Date:  2004-05-24       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.